Day 1 (08th MAY, 2024)

 

Stream A : Site Staffing and Retention

  • Training and development strategies to ensure highly skilled and competent site workforce
  • Enhancing Diversity and Inclusion in Clinical Trial Site Staffing and Retention
  • Panel Discussion : Mission To Improve Communication With Patients, Sites, And CROs: Lessons from Big Pharma
  • Reducing the Burden of Clinical Trial Execution via Site-Focused Support
  • Collaborating for Advancement: The Essential Role of Community Engagement in Supporting Investigative Sites and Promoting Trial Diversity

 

Stream B: Patient Recruitment & Enrollment 

    • Panel Discussion: Bringing the patient voice in the design of clinical trials: why, when and how
    • Engaging and Understanding Patients and HCPs to Improve Accessibility, Enrollment, Retention, and Outcomes
    • A new holistic approach : Partnering with Social Influencers to Drive Enrollment
    • Hybrid Trials, DCTs, and Patient-Centricity: Where Are We Now and Where Are We Going?

Day 2 (09th MAY, 2024)

Stream C: Feasibility and Study Start up

  • Panel Discussion: Big Pharma’s Strategy for Expediting Clinical Development: Recognizing the Value of Time
  • Prioritizing the Site Experience: Reducing Negotiations, Establishing Consistent Timelines, and Simplifying Study Close-Out Processes
  • Utilizing Decentralized Methods with Experienced Research Centres: Developing Clinical Trials That Focus on Rare Diseases and Oncology
  • Delve into the possibilities of AI and machine learning in enhancing site operations and trial management
  • Utilizing data analytics and technology to identify ideal clinical trial sites

 

Stream D: Clinical Trial Forecasting, Budgeting and Partnerships

  • Panel Discussion: Improving operational efficiency to minimize modifications and foster stronger collaboration between sponsors, CROs, and sites.
  • Managing clinical trials in financially uncertain times involves effectively navigating the influence of the biotech market on budgeting and contracting.
  • Panel Discussion: Why Alliance Management and Change Management are Interconnected: Enhancing Value in the Pharma-CRO Partnership
  • Showdown of Clinical Trial Budgeting/Forecasting: Investigator Sites vs. Sponsors – Addressing Budgeting Challenges